swii.ch health: From Patient Identification to Launch: Your Partner in Rare Disease Success
Specialists in Rare Disease Patient Identification, Advocacy, and Education
At SWII.CH, we partner with biopharma companies to address the critical challenges that arise at every stage of the drug lifecycle. Whether you’re navigating early-stage patient identification, driving disease awareness, optimizing engagement strategies, or preparing for launch, our expertise and innovative solutions are designed to meet your unique needs.
PATIENT IDENTIFICATION & RECRUITMENT Using advanced data analytics and tailored outreach strategies, we help you pinpoint and connect with patients earlier in their journey, expediting diagnosis and treatment pathways.
DISEASE AWARENESS & EDUCATION We design targeted campaigns to increase awareness among healthcare providers, patients, and caregivers, ensuring your message resonates and drives action.
ENGAGEMENT STRATEGY & IMPLEMENTATION Our insight-driven approach enables meaningful connections with patients, caregivers, and providers, fostering trust and long-term advocacy.
Embedded in the rare disease community, we partner with advocacy groups, caregivers, and healthcare providers to bridge the gap between biopharma innovation and real-world patient needs.
Our digital tools and behavioural insights empower you to:
Reach patients faster through precision digital outreach.
Inspire action with compelling, data-driven campaigns.
Build trust and advocacy through personalized engagement strategies.
Virtual HTA Advocacy Training: Equipping patient advocates with tools to influence healthcare decision-making.
Digital Behavior Analysis: Understanding HCP and patient engagement patterns to refine strategy.
Interactive Awareness Campaigns: Using digital platforms to increase disease recognition.
Omnichannel Advocacy Network Mapping: Strengthening patient advocacy ecosystems through tailored digital insights.
We chose to work with swii.ch as they demonstrated their unique approach of combining years of patient engagement experience with technical/digital competencies to ensure patients remain central to the solutions we develop.
At the time we were planning to develop a roadmap for our digital strategy for an ultra-rare neuromuscular disease, and the approach swii.ch recommended allowed us to develop a good understanding of the patient’s digital journey for information that enabled us to identify the gaps that exist in the specific disease area. Swii.ch effectively guided the team’s creative thinking around insights gathered through the first phase of the project which enabled us to deliver a plan to develop a structured digital ecosystem that we believe will empower patients and their families/caregivers with information and solutions to live their best lives.
Vice President EMEA - Lupin Neurosciences
I have been engaging with swii.ch in the last 18 months to utilise their services in patient engagement and consultancy. Throughout this time, they have delivered to me qualitative analyses, patient group research and strategic advice, and will be supporting me with various patient and access-related activities.
I would not hesitate to recommend the team for their experience, counsel, transparency, delivery and ability to build good relationships with people both in and outside the company.
Director of Patient Engagement and Advocacy EMEA Alnylam Pharmaceuticals Europe
See our posts
See what we’ve been up to as well as the latest news and opinions in rare diseases
